InvestorsHub Logo
Followers 9
Posts 402
Boards Moderated 0
Alias Born 04/22/2013

Re: goldenisla post# 20546

Monday, 03/05/2018 12:57:22 AM

Monday, March 05, 2018 12:57:22 AM

Post# of 232977
Goldenisla & d0lphin0m:
Let me bring a little context to my forthcoming comments. For the past thirty years I've been selling at a residential, commercial and private business level the most precious commodity of all - money. I've listened to countless pitch sessions and heard people in terribly compromised positions, so I know leverage when I see it.

I define leverage as one party possessing something another party wants or more importantly needs very badly. With regards to PRO-140 none of the top 20 pharma companies NEEDS it, they'll survive just fine without it. Their is no shortage of reports or predictions on where this group will be five years from now, they all have robust pipelines, their will simply be a shuffling of the deck, a rearrangement of ranked positions if you will.

So they don't need us, we need them. And I stick to the notion that Gilead has most to lose if a competitor would purchase CYDY, the gutting of their HIV revenue would be catastrophic - so they still might be the likeliest suitor.

But at this point in time, with what we know and how far down the line we are in the various trials I don't see them paying more than $3.00 unless threatened by a rival. I would welcome an R/S to up list and believe it would help with fund raising. The current track is untenable and unforgiving - too much decay through dilution-
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News